Free Trial

Neuronetics (STIM) SEC Filings & 10K Form

Neuronetics logo
$1.39 +0.10 (+7.75%)
(As of 12/20/2024 05:31 PM ET)

Recent Neuronetics SEC Filings

DateFilerForm TypeView
12/19/2024
4:54 PM
Madryn Asset Management, LP (Reporting)
MADRYN HEALTH ADVISORS GP II, LLC (Reporting)
MADRYN HEALTH ADVISORS II, LP (Reporting)
MADRYN HEALTH PARTNERS II , LP (0002007791) (Reporting)
Madryn Health Partners II, LP (Reporting)
MADRYN SELECT ADVISORS GP, LLC (Reporting)
MADRYN SELECT ADVISORS, LP (Reporting)
Madryn Select Opportunities, LP (Reporting)
Neuronetics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/19/2024
4:00 PM
Cucuz Sasha (Reporting)
Neuronetics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/19/2024
4:00 PM
Amin Avinash (Reporting)
Neuronetics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/17/2024
8:15 PM
Madryn Asset Management, LP (Filed by)
Neuronetics (Subject)
Form SC 13D
12/12/2024
4:00 PM
Furlong Stephen (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
4:00 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
4:00 PM
Neuronetics (Issuer)
Sullivan Keith J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:45 PM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
1:32 PM
Kent Lake PR LLC (Filed by)
Neuronetics (Subject)
Form SCHEDULE 13G
11/14/2024
10:32 AM
Neuronetics (Subject)
Parian Global Management LP (Filed by)
Form SCHEDULE 13G/A
11/14/2024
10:17 AM
Divisadero Street Capital Management, LP (Filed by)
Neuronetics (Subject)
Form SC 13G/A
11/13/2024
5:44 AM
Neuronetics (Filer)
Form 8-K/A
11/12/2024
6:31 AM
Neuronetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
6:01 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
6:03 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
6:01 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
4:18 PM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
4:20 PM
Neuronetics (Filer)
Form DEFA14A
10/10/2024
4:05 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2024
4:05 PM
Furlong Stephen (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2024
3:30 PM
Neuronetics (Filer)
Form DEFA14A
10/08/2024
2:19 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/08/2024
2:20 PM
Furlong Stephen (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/04/2024
4:06 PM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
7:54 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
7:56 AM
Neuronetics (Filer)
Form DEFA14A
10/04/2024
6:34 AM
Neuronetics (Filer)
Form DEFM14A
09/17/2024
6:32 AM
Neuronetics (Filer)
Form PREM14A
09/13/2024
4:02 PM
CASCELLA ROBERT (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
4:05 PM
MUIR GLENN P (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
4:15 PM
MUIR GLENN P (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
4:15 PM
MUIR GLENN P (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
4:13 PM
CASCELLA ROBERT (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:15 PM
MUIR GLENN P (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:15 PM
CASCELLA ROBERT (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:35 PM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
3:36 PM
Neuronetics (Filer)
Form DEFA14A
08/14/2024
5:17 PM
Archon Capital Management LLC (Filed by)
Neuronetics (Subject)
Form SC 13G/A
08/13/2024
7:56 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
8:00 AM
Neuronetics (Filer)
Form DEFA14A
08/12/2024
4:10 PM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Has Trump Finally Gone Too Far? (Ad)

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

Register For The Webinar To Discover
08/12/2024
4:16 PM
Neuronetics (Filer)
Form DEFA14A
08/12/2024
7:33 AM
Neuronetics (Filer)
Form DEFA14A
08/12/2024
7:32 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
6:30 AM
Neuronetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2024
7:52 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2024
4:23 PM
Neuronetics (Issuer)
Sullivan Keith J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
4:21 PM
Neuronetics (Issuer)
Sullivan Keith J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
3:38 PM
Neuronetics (Subject)
Sullivan Keith J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
3:32 PM
Neuronetics (Subject)
Sullivan Keith J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
2:46 PM
Neuronetics (Subject)
Sullivan Keith J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/28/2024
2:04 PM
Kent Lake Capital LLC (Filed by)
Neuronetics (Subject)
Form SC 13G
06/06/2024
4:15 PM
CASCELLA ROBERT (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
5:05 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
7:19 PM
CONLEY SHERYL L (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:22 PM
CASCELLA ROBERT (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:14 PM
MUIR GLENN P (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:17 PM
Neuronetics (Issuer)
Rosengarten Megan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
6:30 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
6:31 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
4:30 PM
Divisadero Street Capital Management, LP (Filed by)
Neuronetics (Subject)
Form SC 13G
03/25/2024
3:59 PM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2024
8:44 PM
Neuronetics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2024
6:30 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
6:31 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
4:02 PM
Furlong Stephen (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:10 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
3:16 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2024
4:33 PM
Furlong Stephen (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
4:21 PM
Neuronetics (Issuer)
Sullivan Keith J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
3:23 PM
Neuronetics (Subject)
Sullivan Keith J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
2:19 PM
Neuronetics (Subject)
Sullivan Keith J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
3:35 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
10:46 AM
Kent Lake Capital LLC (Filed by)
Neuronetics (Subject)
Form SC 13G/A
02/14/2024
9:21 AM
CANNELL CAPITAL LLC (Filed by)
Neuronetics (Subject)
Form SC 13G/A
02/13/2024
5:00 PM
Furlong Stephen (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
10:10 AM
Archon Capital Management LLC (Filed by)
Neuronetics (Subject)
Form SC 13G/A
02/09/2024
2:39 PM
Furlong Stephen (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/07/2024
4:41 PM
Furlong Stephen (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
4:42 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
5:19 PM
Neuronetics (Issuer)
Sullivan Keith J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
3:44 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/06/2024
3:24 PM
Furlong Stephen (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/12/2024
5:00 PM
Neuronetics (Issuer)
Sullivan Keith J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
2:33 PM
Neuronetics (Subject)
Sullivan Keith J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2024
2:13 PM
Neuronetics (Subject)
Sullivan Keith J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
7:30 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2023
6:42 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2023
10:09 AM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:STIM) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners